Stefan Knapp, PhD, studied chemistry at the University of Marburg in Germany and at the University of Illinois. He did his PhD in protein crystallography at the Karolinska Institute in Stockholm. In 1999, he joined Pharmacia and left the company in 2004 to set up a research group at the Structural Genomics Consortium at Oxford University. From 2008 to 2015, he was a professor of structural biology at Oxford University and from 2012 to 2015 the director for chemical biology at the Target Discovery Institute at Oxford University. He joined Frankfurt University in 2015 as a professor of pharmaceutical chemistry. Since 2017, he has served as the CSO of the Structure Genomics Consortium node at the Goethe-University in Frankfurt. His research interests are unravelling molecular/structural mechanisms of kinase regulation and using high-resolution structures for the design of selective kinase inhibitors and inhibitors of protein interactions domains.
CO-INVESTIGATOR
Stefan Knapp, PhD
Goethe-Universität
Stefan Knapp, PhD, studied chemistry at the University of Marburg in Germany and at the University of Illinois. He did his PhD in protein crystallography at the Karolinska Institute in Stockholm. In 1999, he joined Pharmacia and left the company in 2004 to set up a research group at the Structural Genomics Consortium at Oxford University. From 2008 to 2015, he was a professor of structural biology at Oxford University and from 2012 to 2015 the director for chemical biology at the Target Discovery Institute at Oxford University. He joined Frankfurt University in 2015 as a professor of pharmaceutical chemistry. Since 2017, he has served as the CSO of the Structure Genomics Consortium node at the Goethe-University in Frankfurt. His research interests are unravelling molecular/structural mechanisms of kinase regulation and using high-resolution structures for the design of selective kinase inhibitors and inhibitors of protein interactions domains.
